Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The epidemiology of amyloidosis in Australia.
Wisniowski B, McLeod D, Adams R, Harvey Y, Armes J, Papadimos D, Brown I, McGuire L, Mollee P. Wisniowski B, et al. Amyloid. 2019;26(sup1):132-133. doi: 10.1080/13506129.2019.1582481. Amyloid. 2019. PMID: 31343339 No abstract available.
The epidemiology of amyloidosis in Queensland, Australia.
Wisniowski B, McLeod DSA, Adams R, Harvey Y, Brown I, McGuire L, Armes J, Mollee P. Wisniowski B, et al. Br J Haematol. 2019 Sep;186(6):829-836. doi: 10.1111/bjh.16000. Epub 2019 May 31. Br J Haematol. 2019. PMID: 31148162 Free article. Clinical Trial.
The experience of hereditary apolipoprotein A-I amyloidosis at the UK National Amyloidosis Centre.
Cohen OC, Blakeney IJ, Law S, Ravichandran S, Gilbertson J, Rowczenio D, Mahmood S, Sachchithanantham S, Wisniowski B, Lachmann HJ, Whelan CJ, Martinez-Naharro A, Fontana M, Hawkins PN, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: wisniowski b. Amyloid. 2022 Dec;29(4):237-244. doi: 10.1080/13506129.2022.2070741. Epub 2022 May 3. Amyloid. 2022. PMID: 35502644
Confirming the Diagnosis of Amyloidosis.
Wisniowski B, Wechalekar A. Wisniowski B, et al. Acta Haematol. 2020;143(4):312-321. doi: 10.1159/000508022. Epub 2020 Jun 16. Acta Haematol. 2020. PMID: 32544917 Free article. Review.
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
Chan WY, Howells L, Wilson W, Sanchez E, Ainley L, Chavda SJ, Dowling E, Correia N, Lecat CSY, McMillan A, Wisniowski B, Mahmood S, Papanikolaou X, Lee L, Sive J, Kyriakou C, Wechalekar A, Popat R, Rabin N, Nastouli E, Yong KL, Xu K. Chan WY, et al. Among authors: wisniowski b. Br J Haematol. 2022 Feb;196(3):e21-e26. doi: 10.1111/bjh.17864. Epub 2021 Oct 10. Br J Haematol. 2022. PMID: 34632575 Free PMC article. No abstract available.
Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.
Howells L, Chan WY, Sanchez E, Horder J, Newrick F, Marfil J, McMillan A, Wisniowski B, Mahmood S, Papanikolaou X, Lee L, Wechalekar A, Popat R, Sive J, Kyriakou C, Xu K, Nastouli E, Yong KL, Rabin N. Howells L, et al. Among authors: wisniowski b. Leuk Lymphoma. 2022 Oct;63(10):2489-2493. doi: 10.1080/10428194.2022.2074989. Epub 2022 May 14. Leuk Lymphoma. 2022. PMID: 35570744 No abstract available.
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis.
Muchtar E, Dispenzieri A, Wisniowski B, Palladini G, Milani P, Merlini G, Schönland S, Veelken K, Hegenbart U, Geyer SM, Kumar SK, Kastritis E, Dimopoulos MA, Liedtke M, Witteles R, Sanchorawala V, Szalat R, Landau H, Petrlik E, Lentzsch S, Coltoff A, Bladé J, Cibeira MT, Cohen O, Foard D, Wechalekar A, Gertz MA. Muchtar E, et al. Among authors: wisniowski b. J Clin Oncol. 2023 Mar 1;41(7):1393-1403. doi: 10.1200/JCO.22.00643. Epub 2022 Oct 10. J Clin Oncol. 2023. PMID: 36215675 Free PMC article.
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
Martinez-Naharro A, Patel R, Kotecha T, Karia N, Ioannou A, Petrie A, Chacko LA, Razvi Y, Ravichandran S, Brown J, Law S, Quarta C, Mahmood S, Wisniowski B, Pica S, Sachchithanantham S, Lachmann HJ, Moon JC, Knight DS, Whelan C, Venneri L, Xue H, Kellman P, Gillmore JD, Hawkins PN, Wechalekar AD, Fontana M. Martinez-Naharro A, et al. Among authors: wisniowski b. Eur Heart J. 2022 Dec 1;43(45):4722-4735. doi: 10.1093/eurheartj/ehac363. Eur Heart J. 2022. PMID: 36239754 Free PMC article.
Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.
Chan WY, Sanchez E, Chavda SJ, Lecat CSY, Ainley L, Xu K, Wisniowski B, Mahmood S, Papanikolaou X, Kyriakou C, Sive J, Wechalekar A, Popat R, Rabin N, Lee L, Nastouli E, Yong KL. Chan WY, et al. Among authors: wisniowski b. Br J Haematol. 2021 Sep;194(5):857-861. doi: 10.1111/bjh.17441. Epub 2021 Jul 29. Br J Haematol. 2021. PMID: 34323287 Free PMC article. No abstract available.
Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma.
Asher S, Kazantzi A, Dekaj F, Steventon L, Khatun A, Ainley L, McMillan A, Rabin N, Wechalekar A, Sive J, Kyriakou C, Papanikolaou X, Xu K, Mahmood S, Wisniowski B, Lee L, Yong K, Popat R. Asher S, et al. Among authors: wisniowski b. Haematologica. 2022 Dec 1;107(12):2961-2965. doi: 10.3324/haematol.2022.281322. Haematologica. 2022. PMID: 36005557 Free PMC article. No abstract available.
36 results